参考文献/References:
[1] MESSMER EM.The pathophysiology,diagnosis,and treatment of dry eye disease[J].Dtsch Arztebl Int,2015,112(5):71-81.
[2] YAGCI A,GURDAL C.The role and treatment of inflammation in dry eye disease[J].Int Ophthalmol,2014,34(6):1291-1301.
[3] STUMHOFER JS,HUNTER CA.Advances in understanding the anti-inflammatory properties of IL-27[J].Immunol Lett,2008,117(2):123-130.
[4] SILVA WA JR,COVAS DT,PANEPUCCI RA,PROTO-SIQUEIRA R,SIUFI JL,ZANETTE DL,et al.The profile of gene expression of human marrow mesenchymal stem cells[J].Stem Cells,2003,21(6):661-669.
[5] ZHU Z,ZHU Z,PANG Z,XING Y,LAN D,WANG H.Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer[J].Int J Oncol,2013,42(4):1271-1278.
[6] 中华医学会眼科学分会角膜病学组.干眼临床诊疗专家共识(2013年)[J].中华眼科杂志,2013,49(1):73-75.
COREAL DISEASE STUDY GROUP OF OPHTHALMOLOGY BRANCH OF CHINESE MEDICAL ASSOCIATION.Consensus of clinical experts on dry eye(2013)[J].Chin J Ophthalmol,2013,49(1):73-75.
[7] CROME SQ,CLIVE B,WANG AY,KANG CY,CHOW V,YU J,et al.Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells[J].J Immunol,2010,185(6):3199-3208.
[8] CHAMBERIAIN G,FOX J,ASHTON B,MIDDLETON J.Concise review:mesenchymal stem cells:their phenotype,differentiation capacity,immunological features,and potential for homing[J].Stem Cells,2007,25(11):2739-2749.
[9] JIA Z,JIAO C,ZHAO S,LI X,REN X,ZHANG L,et al.Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model[J].Exp Eye Res,2012,102(6):44-49.
[10] BASSI EJ,DE ALMEIDA DC,MORAES-VIEIRA PM,CAMARA NO.Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells[J].Stem Cell Rev,2012,8(2):329-342.
[11] EL ANNAN J,CHAUHAN SK,ECOIFFIER T,ZHANG Q,SABAN DR,DANA R.Characterization of effector T cells in dry eye disease[J].Invest Ophthalmol Vis Sci,2009,50(8):3802-3807.
[12] BETTELLI E,CARRIER Y,GAO W,KORN T,STROM TB,OUKKA M,et al.Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells[J].Nature,2006,441(7090):235-238.
[13] PFLUGFELDER SC.What causes dryness in Sjgren’s syndrome patients and how can it be targeted[J]?Exp Clin Immunol,2014,10(4):425-427.
[14] TROUSDALE MD,ZHU Z,STEVENSON D,SCHECHTER JE,RITTER T,MIRCHEFF AK.Expression of TNF inhibitor gene in the lacrimal gland promotes recovery of tear production and tear stability and reduced immunopathology in rabbits with induced autoimmune dacryoadenitis[J].J Autoimmune Dis,2005,2(1):6.
[15] ROESCHER N,TAK PP,ILLEI GG.Cytokines in Sjgren’s syndrome:potential therapeutic targets[J].Ann Rheum Dis,2010,69(6):945-948.
[16] MOHAMMADZADEH A,POURFATHOLLAH AA,SHAHROKHI S,HASHEMI SM,MORADI SL,SOLEIMANI M.Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors of T cell subsets[J].Int Immunopharmacol,2014,20(2):316-321.
[17] GREGORINI M,BOSIO F,ROCCA C,CORRADETTI V,VALSANIA T,PATTONIERI EF,et al.Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation[J].BMC Immunol,2014,15(1):44.
[18] LAROCCA RA,MORAESVIEIRA PM,BASSI EJ,SEMEDO P,DE ALMEIDA DC,DA SILVA MB,et al.Adipose tissue-derived mesenchymal stem cells increase skin allograft survival and inhibit Th-17 immune response[J].PLoS One,2013,8(10):e76396-76396.
[19] ZHANG X,REN X,LI G,JIAO C,ZHANG L,ZHAO S,et al.Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity[J].Invest Ophthalmol Vis Sci,2011,52(6):3143-3152.
[20] REN H,SANG Y,ZHANG F,IU Z,QI N,CHEN Y.Comparative analysis of human mesenchymal stem cells from umbilical cord,dental pulp,and menstrual blood as sources for cell therapy[J].Stem Cells Int,2016,2016:3516574.
相似文献/References:
[1]贾喆 张晓敏 赵少贞.间充质干细胞对异体角膜移植大鼠CD4+ CD25+ Foxp3+调节性T细胞水平的影响[J].眼科新进展,2012,32(4):000.
[2]秦力维 高原 郭建巍.间充质干细胞治疗眼免疫性疾病的新进展[J].眼科新进展,2013,33(9):000.
[3]李芳,李轩.间充质干细胞在角膜重建中的应用研究进展[J].眼科新进展,2015,35(11):1083.[doi:10.13389/j.cnki.rao.2015.0297]
LI Fang,LI Xuan.Research progress on applications of MSC in cornea reconstruction[J].Recent Advances in Ophthalmology,2015,35(8):1083.[doi:10.13389/j.cnki.rao.2015.0297]
[4]高凡,王雨生,侯慧媛.两种缺氧模型对小鼠骨髓间充质干细胞中基质金属蛋白酶表达及其对促血管形成能力的影响[J].眼科新进展,2016,36(5):401.[doi:10.13389/j.cnki.rao.2016.0108]
GAO Fan,WANG Yu-Sheng,HOU Hui-Yuan.Effects of two hypoxia models on expression of matrix metalloproteinase in mesenchymal stem cells and their pro-angiogenesis action[J].Recent Advances in Ophthalmology,2016,36(8):401.[doi:10.13389/j.cnki.rao.2016.0108]
[5]张琛,路晓晓,粘红,等.间充质干细胞治疗干眼的研究进展[J].眼科新进展,2017,37(3):289.[doi:10.13389/j.cnki.rao.2017.0073]
ZHANG Chen,LU Xiao-Xiao,NIAN Hong,et al.Research progression on mesenchymal stem cells in dry eye[J].Recent Advances in Ophthalmology,2017,37(8):289.[doi:10.13389/j.cnki.rao.2017.0073]
[6]王希莲,路晓晓,杨丽媛,等.间充质干细胞对自身免疫性干眼的免疫调控作用研究进展[J].眼科新进展,2017,37(5):480.[doi:10.13389/j.cnki.rao.2017.0122]
WANG Xi-Lian,LU Xiao-Xiao,YANG Li-Yuan,et al.Recent advances in immune regulation of mesenchymal stem cells on autoimmune dry eye[J].Recent Advances in Ophthalmology,2017,37(8):480.[doi:10.13389/j.cnki.rao.2017.0122]
[7]韩新红,李艳,李聪伶,等.色素上皮衍生因子基因修饰的脐带间充质干细胞对糖尿病大鼠视网膜组织病理改变的影响[J].眼科新进展,2018,38(2):126.[doi:10.13389/j.cnki.rao.2018.0027]
HAN Xin-Hong,LI Yan,LI Cong-Ling,et al.Pathological changes in retinal tissue in diabetic rats treated with PEDF gene-modified umbilical cord mesenchymal stem cells[J].Recent Advances in Ophthalmology,2018,38(8):126.[doi:10.13389/j.cnki.rao.2018.0027]
[8]贾喆,李斐,吕瑛,等.间充质干细胞来源外泌体(MSCs-exo)对大鼠角膜移植排斥反应的抑制作用[J].眼科新进展,2018,38(11):1010.[doi:10.13389/j.cnki.rao.2018.0238]
JIA Zhe,LI Fei,LV Ying,et al.Suppressive effect of exosomes derived from mesenchymal stem cells on keratoplasty rejection[J].Recent Advances in Ophthalmology,2018,38(8):1010.[doi:10.13389/j.cnki.rao.2018.0238]
[9]张梦瑶,汪水风,邵毅.干眼的再生疗法研究进展[J].眼科新进展,2019,39(12):1192.[doi:10.13389/j.cnki.rao.2019.0274]
ZHANG Meng-Yao,WANG Shui-Feng,SHAO Yi.Regenerative medicine in dry eye[J].Recent Advances in Ophthalmology,2019,39(8):1192.[doi:10.13389/j.cnki.rao.2019.0274]
[10]李东丽,宫媛媛.间充质干细胞源性外泌体对前部缺血性视神经病变患者的治疗潜力[J].眼科新进展,2020,40(5):492.[doi:10.13389/j.cnki.rao.2020.0113]
LI Dongli,GONG Yuanyuan.Therapeutic potential of mesenchymal stem cells-exosomes for anterior ischemic optic neuropathy[J].Recent Advances in Ophthalmology,2020,40(8):492.[doi:10.13389/j.cnki.rao.2020.0113]
[11]王希莲,杨丽媛,粘红,等.人脐带间充质干细胞对兔自身免疫性干眼的疗效研究[J].眼科新进展,2017,37(1):019.[doi:10.13389/j.cnki.rao.2017.0005]
WANG Xi-Lian,YANG Li-Yuan,NIAN Hong,et al.Treatment effect of mesenchymal stem cells on rabbit autoimmune dry eye[J].Recent Advances in Ophthalmology,2017,37(8):019.[doi:10.13389/j.cnki.rao.2017.0005]